Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Request House co-sponsorship for H.R. 2938, the "Road to Recovery Act," sponsored by Rep. Brian Fitzpatrick (R-PA). This legislation would permanently extract substance use disorder treatment from the IMD Exclusion. Seek a Senate companion bill sponsor for H.R. 2938, the "Road to Recovery Act," sponsored by Rep. Brian Fitzpatrick (R-PA). This legislation would permanently extract substance use disorder treatment from the IMD Exclusion.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ODYSSEY HOUSE LOUISIANA via THE LAFAYETTE COMPANY, LLC
2017 · third_quarter · Q3
Request House co-sponsorship for H.R. 2938, the "Road to Recovery Act," sponsored by Rep. Brian Fitzpatrick (R-PA). This legislation would permanently extract substance use disorder treatment from the IMD Exclusion. Seek a Senate companion bill sponsor for H.R. 2938, the "Road to Recovery Act," sponsored by Rep. Brian Fitzpatrick (R-PA). This legislation would permanently extract substance use disorder treatment from the IMD Exclusion.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
2017 · second_quarter · Q2
Separating mental health and substance abuse in law and regulations; requesting the delay or permanent suspension of the implementation of an Obama Administration CMS rule that limits in-patient substance abuse treatment to 15 consecutive days in a month; request consideration for client's placement on government advisory panels on the opioid crisis
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
ODYSSEY HOUSE LOUISIANA via THE LAFAYETTE COMPANY, LLC
2017 · first_quarter · Q1
Separating mental health and substance abuse in law and regulations; requesting the delay or permanent suspension of the implementation of an Obama Administration CMS rule that limits in-patient substance abuse treatment to 15 consecutive days in a month; request consideration for client's placement on government advisory panels on the opioid crisis
Filing targets: Health & Human Services, Dept of (HHS)
ODYSSEY HOUSE LOUISIANA via THE LAFAYETTE COMPANY, LLC
2017 · first_quarter · RR
Request suspension of Obama Administration CMS rule limiting in-patient treatment of substance abuse to just 15 days in a calendar month; Request separation of mental health and substance abuse in legislative and regulatory action.